Key points are not available for this paper at this time.
This pilot study showed that the AndroidAPS system was a safe and feasible alternative to the SmartGuard Technology.
Petruželková et al. (Thu,) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: